Search Login Register

Neoplasms (Cancer) Summary

Description: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Also Known As: Cancer; Tumor; Tumors; Cancers; Neoplasm Show All >>

Networked: 516559 relevant articles (25767 outcomes, 65775 trials/studies) for this Disease

Key Drugs and Agents for Neoplasms

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Cisplatin (Platino) : 656 outcomes 1174 studies in 7161 results : FDA 6 Generic
  2. Antigens : 654 outcomes 1866 studies in 20512 results : IBA
  3. DNA (Deoxyribonucleic Acid) : 516 outcomes 2036 studies in 23128 results : IBA
  4. Doxorubicin (Adriamycin) : 459 outcomes 663 studies in 5201 results : FDA 12 Generic
  5. Paclitaxel (Taxol) : 368 outcomes 797 studies in 3528 results : FDA 13 Generic
  6. Fluorouracil (Carac) : 361 outcomes 718 studies in 4504 results : FDA 33 Generic
  7. Interleukin-2 (IL2) : 348 outcomes 539 studies in 3991 results : IBA
  8. Hormones : 298 outcomes 1010 studies in 9653 results : IBA
  9. Vaccines : 280 outcomes 371 studies in 2853 results : IBA
  10. Antibodies : 276 outcomes 793 studies in 8144 results : IBA
Show All >>

Diseases Related to Neoplasms

  1. Neoplasms (Cancer)
  2. Neoplasm Metastasis (Metastasis)
  3. Pain (Aches)
  4. Breast Neoplasms (Breast Cancer)
  5. Carcinoma (Carcinomatosis)
Show All >>

Key Therapies for Neoplasms

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 3342 outcomes 4749 studies in 42507 results
  2. Radiotherapy : 1247 outcomes 1773 studies in 18563 results
  3. Heterologous Transplantation (Xenotransplantation) : 888 outcomes 1630 studies in 12704 results
  4. Immunotherapy : 755 outcomes 1100 studies in 9625 results
  5. Therapeutics : 218 outcomes 302 studies in 3670 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2013 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.